MedTrace Logo

Treating Major Depression With Yoga Mono-therapy

NCT06091527 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-11-06

No results posted yet for this study

Summary

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Conditions

  • Depression Mild
  • Depression Moderate

Interventions

BEHAVIORAL

Yoga practice

90-minute group yoga classes twice weekly for 12 weeks.

BEHAVIORAL

Education

90-minute group education classes twice weekly for 12 weeks to learn holistic healthcare modules.

Sponsors & Collaborators

Principal Investigators

  • Sudha Prathikanti, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-25
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06091527 on ClinicalTrials.gov